Acrivon Therapeutics Inc. Common Stock

NASDAQ ACRV

Data sourced from iex and EODHD
Download Data

Acrivon Therapeutics Inc. Common Stock Income Statement 2021 - 2024

This table shows the Income Statement for Acrivon Therapeutics Inc. Common Stock going from 2021 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-03-31
Revenue
M 0 2 0 0 0 0 0 0 0 0 0 -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - -
Gross Profit
M 0 2 0 0 0 0 - - - - - -
Operating Expenses
M 17 23 16 15 14 10 - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 6 6 6 5 5 4 2 2 1 1 0 -
Research and Development (R&D) Expenses
M 11 15 10 11 10 6 8 4 6 3 2 -
Other Operating Expenses
M 0 2 0 0 0 0 - - - - - -
Costs and Expenses
M 17 21 16 15 14 10 - - - - - -
Operating Income
M -18 -21 -16 -16 -14 -10 -10 -6 -7 -4 -3 -
Interest Expense
M - 2 - - -2 1 0 0 0 0 - -
Non-operating Income/Expense
M 1 2 2 2 2 1 0 0 0 0 0 -
EBT
M -16 -19 -14 -14 -13 -9 -9 -6 -7 -4 -2 -
Income Tax Provision
M - 2 0 - -2 -1 0 0 0 0 0 -
Income after Tax
M - -21 -14 - -11 -8 -9 -6 -7 -4 -2 -
Non-Controlling Interest
M - - - 0 0 0 0 1 -1 -1 1 -
Net Income
M - - - -14 -13 -9 -9 -7 -7 -3 -3 -5
Shares (Basic, Weighted)
M - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 22,590,804.00 22,335,407.00 22,081,162.00 21,971,032.00 21,920,570.00 11,093,563.00 18,809,823.00 12,909,823.00 12,909,823.00 12,909,823.00 12,909,823.00 -
EBITDA
M -17 -21 -16 -15 -14 -10 -9 -6 -7 -4 -3 -
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -18 -21 -16 -16 -14 -10 -10 -6 -7 -4 -3 -5
Income from Discontinued Operations
M - - - - - - - - - - - -
Tax Rate (Effective)
% - -9.19 0.92 - 12.83 11.38 4.10 1.80 -0.11 -1.68 9.47 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% - 92.09 - - - - - - - - - -
Operating Income Margin
% - -1,117.46 - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - -
EBITDA Ratio
% - -1,109.55 - - - - - - - - - -
EBIT Ratio
% - -1,117.46 - - - - - - - - - -
EBT Ratio
% - -1,021.87 - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email